Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Colorcon
Express Scripts
Dow
AstraZeneca

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Litigation Details for Boehringer Ingelheim International GMBH v. Barr Laboratories, Inc. (D. Del. 2005)

See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Boehringer Ingelheim International GMBH v. Barr Laboratories, Inc.
Biologic Drugs cited in Boehringer Ingelheim International GMBH v. Barr Laboratories, Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Boehringer Ingelheim International GMBH v. Barr Laboratories, Inc. (D. Del. 2005)

Date Filed Document No. Description Snippet Link To Document
2005-10-28 10 Exhibit A infringes U.S. PatentNo. 6,673,337 (the “‘337 patent”) and U.S. Patent No. 6,641,834 (the “‘834 patent”) because…claimed in a patent or the use ofwhich is claimed in a patent before the expiration of such patent. 35 u.s.c…Act for a drug claimed in a patent orthe use of which is claimed in a patent if the purpose of such submission…ofthe ‘337 and ‘834 patents and, as such, its infringement ofthe ‘337 and ‘834 patents is willful. (Id. …on August 24, 2004. Allergan filed this suit for patent infringement pursuant to 35 U.S.C. § 271(€)(2). External link to document
2006-11-09 105 Motion to Amend/Correct filed in this case, one of the patents in suit, U.S. Patent No. 4,843,086, has expired The addition of …one of the patents in suit and to assert a defense and counterclaim that one of the patents in suit is…inequitable conduct The addition of a defense of patent expiration is plainly appropriate given that, since…26 September 2005 1:05-cv-00700-JJF Patent District Court, D. Delaware External link to document
2006-11-13 107 Amended Answer to Complaint Labs admits that United States Patent No. 4,843,086 (“the ‘086 patent"), entitled “Tetrahydro-Benzthiazoles…Products”), and (b) United States Patent No. 4,843,086 (“the ‘086 patent”) is invalid and not infringed …claim of the ‘086 patent; (d) The ‘812 patent be declared invalid; (e) The ‘086 patent be declared invalid… Labs admits that United States Patent No. 4,886,812 (“the ‘812 patent”), entitled Wl`etrahydro-Benzthiazoles…thereto is claimed by the ‘812 patent and if, and only if, the ‘812 patent is valid and enforceable Barr External link to document
2006-11-20 110 Letter asserted two patents against Barr in this litigation: U.S. Patent No. 4,843,086 (“the ’086 patent) and U.S….S. Patent No. 4,886,8l2 (“the ’SlZ patent”). Both the ’086 and ’SlZ patents are descendants of an original… States patent application that ultimately led to the issuance of a third patent, U.S. Patent No. 4,731,374…the ’374 patent”). The patents-in-suit also claim priority back to two original Gerrnan patent applications…filing of patent applications worldwide, the two German patent applications to which the patents~in-suit External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Merck
Moodys
Medtronic
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.